- Home
- ABOS vs EHI Comparison
ABOS vs EHI Comparison
Compare ABOS & EHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- EHI
- Stock Information
- Founded
- ABOS 1996
- EHI 2003
- Country
- ABOS United States
- EHI United States
- Employees
- ABOS N/A
- EHI N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- EHI Investment Managers
- Sector
- ABOS Health Care
- EHI Finance
- Exchange
- ABOS Nasdaq
- EHI Nasdaq
- Market Cap
- ABOS 99.1M
- EHI N/A
- IPO Year
- ABOS 2021
- EHI N/A
- Fundamental
- Price
- ABOS $1.56
- EHI $6.61
- Analyst Decision
- ABOS Strong Buy
- EHI
- Analyst Count
- ABOS 3
- EHI 0
- Target Price
- ABOS $9.33
- EHI N/A
- AVG Volume (30 Days)
- ABOS 379.4K
- EHI 44.5K
- Earning Date
- ABOS 11-12-2024
- EHI 01-01-0001
- Dividend Yield
- ABOS N/A
- EHI 11.54%
- EPS Growth
- ABOS N/A
- EHI N/A
- EPS
- ABOS N/A
- EHI N/A
- Revenue
- ABOS N/A
- EHI N/A
- Revenue This Year
- ABOS N/A
- EHI N/A
- Revenue Next Year
- ABOS N/A
- EHI N/A
- P/E Ratio
- ABOS N/A
- EHI N/A
- Revenue Growth
- ABOS N/A
- EHI N/A
- 52 Week Low
- ABOS $1.54
- EHI $6.00
- 52 Week High
- ABOS $5.09
- EHI $7.75
- Technical
- Relative Strength Index (RSI)
- ABOS 30.29
- EHI 45.46
- Support Level
- ABOS $1.69
- EHI $6.52
- Resistance Level
- ABOS $1.88
- EHI $6.65
- Average True Range (ATR)
- ABOS 0.13
- EHI 0.07
- MACD
- ABOS -0.00
- EHI -0.00
- Stochastic Oscillator
- ABOS 4.88
- EHI 50.00
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.